RefleXion aims to expand radiotherapy as an option for more patients with metastatic disease.
See Clinical Evidence
BgRT uses emissions from the cancer itself to guide treatment in real time – as opposed to yesterday’s images. The RefleXion platform is designed to allow for smaller tumor margins to spare even more healthy tissue.
Learn more about RefleXion’s breakthrough technology.
Learn how RefleXion BgRT is being designed from the ground up to treat multiple tumors in parallel during a single session.
See how RefleXion BgRT unlocks the potential of PET tracers – now and in the future.
Learn more about RefleXion technology and what makes our machine unique.
The RefleXion platform is designed to deliver industry-leading CT-guided IMRT and SBRT while adding BgRT as a new modality. Combined with fan-beam kVCT imaging, RefleXion aims to reduce the risks of radiotherapy while delivering a powerful blow to the target.
Finally, radiotherapy envisioned from the ground up to treat any stage of cancer. Our goal is to make definitive radiotherapy a viable option for hundreds of thousands of patients who are not currently candidates for radiotherapy or do not have access to it today.
For many patients, the best treatment plan is a combination of multiple therapies. Clinical evidence suggests that radiotherapy, in combination with chemotherapy, immunotherapy or targeted drugs may improve outcomes. BgRT has the potential to simplify the use of radiotherapy for all patients, including those with metastatic cancer. This will enable doctors to explore combination therapies involving radiation for more patients than ever before.
Let us tell you more.
Contact UsStay up to date.
Sign Up
